Literature DB >> 14976671

Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism?

John R DeQuardo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14976671     DOI: 10.4088/jcp.v65n0122b

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  5 in total

Review 1.  A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder.

Authors:  Hiroyoshi Takeuchi; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2013-06-05       Impact factor: 4.530

2.  Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.

Authors:  Masayuki Takase; Nobuhisa Kanahara; Yasunori Oda; Hiroshi Kimura; Hiroyuki Watanabe; Masaomi Iyo
Journal:  J Psychopharmacol       Date:  2015-03-03       Impact factor: 4.153

Review 3.  Polypharmacy in pediatric patients and opportunities for pharmacists' involvement.

Authors:  Alexis E Horace; Fahamina Ahmed
Journal:  Integr Pharm Res Pract       Date:  2015-08-21

Review 4.  Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia.

Authors:  Nobuhisa Kanahara; Hiroshi Kimura; Yasunori Oda; Fumiaki Ito; Masaomi Iyo
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

5.  A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder.

Authors:  Leslie Citrome
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.